$11.00
arrow_drop_up4.71%Key Stats | |
---|---|
Open | $12.28 |
Prev. Close | $12.00 |
EPS | -5.46 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $233.91M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 11.16 | 12.25 |
52 Week Range | 6.50 | 28.04 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -5.46 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Water Tower Research Publishes Initiation of Coverage Report on Cybin, Inc., “A Leader in Novel Neuropsychiatry Therapeutics”
What Makes Cybin Inc. (CYBN) a New Buy Stock
Down -17.45% in 4 Weeks, Here's Why Cybin Inc. (CYBN) Looks Ripe for a Turnaround
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
Cybin (CYBN) Begins Phase II Study on Anxiety Drug, Stock Up
Brian's Big Idea on Biotech